Whether a GLP-1 is used before or after bariatric surgery depends on what the care team is trying to achieve. One study examined heart and kidney complications after surgery in patients with a prior prescription. Other studies examined weight loss when medication was added after the operation. Guidance about GLP-1 use around anesthesia answers a separate question about safety during a procedure.[1][2][4][5]
What the preoperative study found
Researchers matched 11,052 patients with a prior GLP-1 or tirzepatide prescription to 11,052 without one. The researchers counted events over the first 90 days after surgery. The major cardiovascular composite occurred in 36 prior users (0.3%) and 67 controls (0.6%). The hazard ratio was 0.535 (95% CI 0.357–0.803). Kidney events occurred in 158 prior users (1.4%) and 256 controls (2.3%).[1]
Prior use meant a prescription 7 to 365 days before the operation. The researchers excluded prescriptions closer to surgery. Prescription dates cannot establish when patients last took medication. Matching cannot account for every difference between patients. The study cannot establish that treatment before surgery prevents these complications.[1]
What studies found after surgery
A study of semaglutide after sleeve gastrectomy included 103 patients. Treatment began one month after surgery and continued through month six. At one year, the semaglutide group had lost 35.14% of its preoperative weight. The surgery-only group had lost 30.73%. The study did not randomly assign treatment.[2]
A systematic review examined treatment after weight regain or limited weight loss. At 12 months, separate analyses for semaglutide and liraglutide each estimated roughly 9% weight loss. The estimates varied substantially across studies. The randomized BARI-STEP trial enrolled adults at least one year after bypass or sleeve surgery. They had lost less than 20% of their body weight. Over 68 weeks, the semaglutide group lost about 19 percentage points more than the placebo group. These estimates come from different populations and study designs.[3][4]
Ask your bariatric team and prescribing clinician to coordinate any medication changes. The American Society of Anesthesiologists says most patients can continue before a procedure. It advises individual planning when risks are higher.[5]